BIOMAT Database Logo BIOMAT Database Logo

Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. 1982

J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin

UI MeSH Term Description Entries
D007123 Immunoelectrophoresis, Two-Dimensional Immunoelectrophoresis in which a second electrophoretic transport is performed on the initially separated antigen fragments into an antibody-containing medium in a direction perpendicular to the first electrophoresis. Immunoelectrophoresis, Crossed,Immunoelectrophoresis, 2-D,Immunoelectrophoresis, 2D,2-D Immunoelectrophoresis,2D Immunoelectrophoresis,Crossed Immunoelectrophoresis,Immunoelectrophoresis, 2 D,Immunoelectrophoresis, Two Dimensional,Two-Dimensional Immunoelectrophoresis
D011697 Purpura, Thrombotic Thrombocytopenic An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases. Moschkowitz Disease,Purpura, Thrombotic Thrombopenic,Thrombotic Thrombocytopenic Purpura, Congenital,Thrombotic Thrombocytopenic Purpura, Familial,Congenital Thrombotic Thrombocytopenic Purpura,Familial Thrombotic Thrombocytopenia Purpura,Familial Thrombotic Thrombocytopenic Purpura,Microangiopathic Hemolytic Anemia, Congenital,Moschcowitz Disease,Schulman-Upshaw Syndrome,Thrombotic Microangiopathy, Familial,Thrombotic Thrombocytopenic Purpura,Upshaw Factor, Deficiency of,Upshaw-Schulman Syndrome,Familial Thrombotic Microangiopathy,Microangiopathy, Familial Thrombotic,Schulman Upshaw Syndrome,Thrombocytopenic Purpura, Thrombotic,Thrombopenic Purpura, Thrombotic,Thrombotic Thrombopenic Purpura,Upshaw Schulman Syndrome
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura.
September 2004, Journal of thrombosis and haemostasis : JTH,
J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission.
January 1992, The Journal of pediatrics,
J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
May 1997, Blood,
J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
von Willebrand factor in thrombotic thrombocytopenic purpura.
August 1999, Thrombosis and haemostasis,
J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
von Willebrand factor in thrombotic thrombocytopenic purpura.
May 1986, Blood,
J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistence of abnormally large von Willebrand factor multimers.
October 1985, American journal of hematology,
J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
von Willebrand factor and thrombotic thrombocytopenic purpura.
September 2000, Current opinion in hematology,
J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
von Willebrand factor proteolysis in thrombotic thrombocytopenic purpura.
November 1999, Blood,
J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
September 1989, The American journal of medicine,
J L Moake, and C K Rudy, and J H Troll, and M J Weinstein, and N M Colannino, and J Azocar, and R H Seder, and S L Hong, and D Deykin
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
October 2002, Journal of molecular medicine (Berlin, Germany),
Copied contents to your clipboard!